Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,126,627
+$43,707 QoQ
Shares Held
12,425
-12.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.14%
of 13F equity value
Holder Rank
#1,629
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GUARDIAN INVESTMENT MANAGEMENT holds $13,312,413 across 7 Drug Manufacturers - General names. ABBV ranks #2 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,205 | $5,868,154 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
12,425 | $3,126,627 | |
| 3 | JNJ |
Johnson & Johnson
|
7,907 | $2,008,140 | |
| 4 | BIIB |
Biogen Inc.
|
5,500 | $1,188,330 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,750 | $473,775 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,300 | $420,626 | |
| 7 | PFE |
Pfizer Inc
|
9,417 | $226,761 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,126,627 | 12,425 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,082,920 | 14,175 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $3,231,991 | 14,145 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,298,287 | 14,245 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,653,437 | 14,295 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,436,128 | 16,400 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $3,163,237 | 17,801 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $3,604,207 | 18,251 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $3,383,403 | 19,726 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $3,683,154 | 20,226 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $3,428,091 | 22,121 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $3,401,698 | 22,821 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $3,071,035 | 22,794 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $4,704,124 | 29,517 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $3,849,065 | 23,817 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $3,196,479 | 23,817 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $4,137,923 | 27,017 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $4,379,725 | 27,017 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $3,576,861 | 26,417 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $2,849,601 | 26,417 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $3,302,266 | 29,317 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $3,194,329 | 29,517 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $3,162,746 | 29,517 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $2,585,394 | 29,517 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,897,979 | 29,517 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $2,347,871 | 30,816 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||